Phase 3 trials of Covaxin begin at AIIMS


The Coronavirus vaccine developed by India, Covaxin has begun it’s phase 3 trials at AIIMS in New Delhi today. It is the first indigenously developed vaccine which will stop Coronavirus. Dr. M V Padma Srivastava is the Chief of the Neurosciences Centre at the institute. He along with three other volunteers are going to receive the first dose in 0.5 ml and will be observed for the next few days, after which it will be given to 15,000 volunteers.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More